NISHITH.TV
  • Mumbai
  • Silicon Valley
  • Bengaluru
  • Singapore
  • Mumbai BKC
  • New Delhi
  • Munich
  • New York

Locations

  • Mumbai
  • Silicon Valley
  • Bengaluru
  • Singapore
  • Mumbai BKC
  • New Delhi
  • Munich
  • New York
  • Content
  • Home
  • ABOUT US
  • NDA in the Media
  • Areas of Service
  • Research and Articles
  • Opportunities
  • Contact
  • NDACloud
  • Client Access
  • Member Access
  • Events and Calender
  • How we perform
  • Knowledge anywhere, anytime
  • See our recent deals
  • Up to date legal developments
  • Case studies in M&A

Research and Articles


  • Research at NDA
  • Research Papers
  • Research Articles
  • NDA Think Tanks
  • NDA Hotline
  • New Ali Gunjan
  • Japan Desk ジャパンデスク

NDA-Hotline


  • Debt Funding in India Series
  • Private Equity Corner
  • The Startups Series
  • Court Corner
  • Investment Funds: Monthly Digest
  • Insolvency and Bankruptcy Hotline
  • Deal Destination
  • New Publication
  • M&A Interactive
  • Lit Corner
  • Private Debt Hotline
  • Food & Beverages Hotline
  • Companies Act Series
  • Gaming Law Wrap
  • Private Client Wrap
  • GIFT City Express
  • Regulatory Hotline
  • Capital Markets Hotline
  • Tax Hotline
  • Corpsec Hotline
  • Dispute Resolution Hotline
  • M&A Hotline
  • Pharma & Healthcare Update
  • Competition Law Hotline
  • HR Law Hotline
  • IP Hotline
  • Telecom Hotline
  • FEMA Hotline
  • Social Sector Hotline
  • iCe Hotline
  • SEZ Hotline
  • Media Hotline
  • Funds Hotline
  • Education Sector Hotline
  • International Trade Hotlines
  • Other Hotline
  • Real Estate Update
  • Realty Check
  • White Collar and Investigations Practice
  • Legal Update
  • IP Lab
  • Cross Examination
  • Technology & Tax Series
  • Technology Law Analysis
  • Yes, Governance Matters.
  • Financial Service Update
  • Japan Desk ジャパンデスク

Pharma & Healthcare Update

1234
TITLE 
DATE 
Pharma Alerts
03-09-2015
Pharma Alerts
04-08-2015
Pharma Manufacturers Breathe Easy: Competition Regulator Treats Old Ailment Affecting the Industry
05-27-2013
Pharma Regulatory Update 2010
02-08-2011
Pharma Round Up: Key Developments in 2019
09-04-2019
Pharma Update - I
09-14-2012
Pharma Update - II
10-23-2012
Pharma Year-End Wrap: Signs of exciting times ahead?
12-31-2019
Pharma Yearly Wrap
12-20-2016
Phase I trials for drugs discovered outside India take a backseat yet again
05-15-2009
Probiotic foods market in India soon to be regulated
12-26-2009
Product promotions - Pharma companies under restrictions
08-29-2011
Prohibition of E-Cigarettes: End of ENDS?
09-20-2019
Recent Mumbai High Court Rulings on Drug Regulations
05-11-2006
Regulated medical devices in India to lose exemption from labelling requirements
07-27-2017
Regulatory Yearly Wrap 2020: Digital Health in India
12-31-2020
Regulatory Yearly Wrap 2020: Healthcare in India
12-30-2020
Regulatory Yearly Wrap 2020: Medical Device in India
12-29-2020
Regulatory Yearly Wrap 2020: Pharmaceuticals in India
12-28-2020
Regulatory Yearly Wrap 2021: Digital Health in India
12-28-2021

Mission and Vision


Distinctly Different

What's New


Mid-year Regulatory Update 2022: Pharmaceuticals in India
Pharma & Healthcare Update: June 24,2022
TCS case may throw spotlight on job termination in IT industry
Quotes : June 23,2022

Events


Webinars

Sustainable Mobility: Opportunities and Challenges
June 09,2022 - June 09,2022

This event is over. For event material please click here


Seminar

Navigating Disputes in India
February 26,2020 - February 26,2020

This event is over. For event material please click here


Round Table

Investing In Net Zero
July 14,2022 - July 14,2022

News Roundup


News Articles

Impact of Supreme Court’s new covidvaccination ruling on India’s employers
May 13,2022

Quotes

TCS case may throw spotlight on job termination in IT industry
June 23,2022

Newsletters


Pharma & Healthcare Update

Mid-year Regulatory Update 2022: Pharmaceuticals in India
June 24,2022

Regulatory Hotline

SEBI’s concerns on Algorithmic Trading by Retail Investors
June 22,2022

Technology Law Analysis

Cyber Security Due Diligence: Should investment committee and board members consider the target’s cyber security readiness before jumping in?
June 20,2022

  • Disclaimer
  • Content
  • Feedback
  • Walkthrough
  • Subscribe
Nishith Desai Associates@2016 All rights reserved.